source
- FDA reexamines previously rejected rare cancer therapy amid claims of political interferenceThe FDA has opened a new review of a treatment for a rare form of cancer that it had turned down a few months earlier. The reconsideration arrives as the agency faces fresh allegations that politi…
- Lung cancer abstracts set to shape discussions at ASCO 2026OncLive has compiled a preview of lung‑cancer presentations that leading oncologists expect to influence clinical talks at the 2026 ASCO Annual Meeting in Chicago. The preview highlights insights f…